Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2009
12/03/2009US20090298824 Organic compounds
12/02/2009EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/02/2009EP2125711A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
12/02/2009CN100564366C Derivatives of 1,3-diones having a herbicidal activity
12/01/2009US7626035 Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
12/01/2009US7626033 Compounds for the modulation of PPARγ activity
12/01/2009US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009US7625933 PPAR gamma agonists or partial agonists; type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity; compounds have a thiazolidinedione or an oxazolidinedione substituent
12/01/2009US7625923 -4-[7-(hydroxy)-tetrahydro-pyrrolo[1,2-c]oxazol-3-ylideneamino]-2-chloro-3-methyl-benzonitrile; non-steroidal, non-toxic; side effect reduction; aging resistance; sarcopenia, osteoporosis and osteopenia, osteoporosis and osteopenia, cancer cachexia, eating disorders (e.g., anorexia) and chemotherapy
12/01/2009US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
11/2009
11/26/2009WO2009140932A2 Method of producing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009US20090291923 Trioxane dimers having high anticancer and long-lasting antimalarial activities
11/26/2009DE102008001932A1 Substiuierte Spiroisoxazoline Substiuierte Spiroisoxazoline
11/25/2009EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009EP2120576A2 Aminoazoline and urea derivatives for combating animal pests
11/25/2009EP2120575A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds
11/25/2009CN101585817A Method for the effective synthesis of optically active oxazoline-2-ketone derivative
11/25/2009CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009CN100562513C Benzamide derivative or salt thereof
11/24/2009US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/24/2009CA2392050C Pharmaceutical formulations containing zolmitriptan
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009139373A1 Amide compound
11/19/2009US20090286988 chemical intermediates such as 2-(3-Methoxyphenyl)-4,5-dimethyloxazole 3-oxide, capable of being transformed to halomethyloxazoles smoothly with high yield and great purity
11/19/2009US20090286985 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009CA2724077A1 Amide compound
11/18/2009EP2118078A2 New salt
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP1789402B1 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy };-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes
11/18/2009EP1660449B1 Aminopropanol derivatives
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/17/2009US7619116 Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
11/17/2009US7618991 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009CA2387464C Process for preparing n-carboxyanhydrides
11/12/2009WO2009137340A1 Alpha2b and alpha2c agonists
11/12/2009WO2009135526A1 Alpha-mercapto-amides
11/12/2009WO2009063505A3 Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide
11/12/2009US20090281309 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
11/12/2009US20090281279 Rigidized trimethine cyanine dyes
11/12/2009US20090281155 Dimeric Small Molecule Potentiators of Apoptosis
11/12/2009US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/12/2009CA2723751A1 Alpha2b and alpha2c agonists
11/12/2009CA2723550A1 Alpha-mercapto-amides
11/11/2009EP2116535A1 Glucokinase-activating substance
11/11/2009EP2116533A1 Glucokinase activator
11/11/2009EP1874745B1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
11/11/2009EP1477186B1 Antipruritics
11/11/2009CN100558814C 树脂组合物 Resin composition
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/05/2009WO2009132740A2 Reactive ionic liquids
11/05/2009US20090275627 Alpha2b and alpha2c agonists
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009US20090274637 Depigmenting or Brigthening Cosmetic Composition at Least One Oxazolin as an Active Ingredient
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/04/2009EP2113031A1 Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
11/04/2009EP1651642B1 Pna monomer and precursor
11/04/2009EP1473286B1 Process for producing biaryl compound
11/04/2009EP1444739B1 Light emitting device and compounds for use therein
11/04/2009EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/03/2009US7612210 Treating (4S or 4R)-4-benzyl-3-[(methoxyphenyl)acetyl]-1,3-oxazolidin-2-one with an aprotic amine base and titanium tetrachloride in chlorinated solvent under conditions which permit formation of corresponding anion, and mixing anion with titanium tetrachloride and cyclohexanone to permit aldol reaction
11/03/2009US7612209 Pseudo proline dipeptides
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009CA2384925C Process for the preparation of oxazole derivatives
10/2009
10/29/2009WO2009132119A2 Substituted oxazolidinones
10/29/2009WO2009129953A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270469 Substituted oxazolidinones
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009CA2722340A1 Small-molecule inhibitors of the androgen receptor
10/29/2009CA2722214A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
10/28/2009EP2112143A1 2-(benzylsulfonyl)-oxazol-derivatives, chiral 2-(benzylsulfinyl]-oxazol derivatives, 2-(benzylsulfanyl-oxazol) derivatives, process for their preparation, as well as their use as herbicide and plant growth regulators
10/28/2009CN101565393A 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
10/28/2009CN100554254C Oxazolidine compound for synthesizing taxone pharmaceutical side-chain and preparation method thereof
10/27/2009US7608721 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009US7608619 [{4-[(4-benzyl-5-pyrrolidin-1-yl-oxazol-2-yl)-piperidin-1-yl-methyl]-cyclohexyl}-(4-fluorophenyl)-methyl]-dimethylamine; depression, urinary incontinence, diarrhoea, pruritus, alcohol and drug misuse, drug dependency, acute pain, neuropathic pain or chronic pain and anxiety
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009WO2009129267A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009WO2009129097A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264487 Hemiasterlin analogs
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264405 Cetp Inhibitors
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2720646A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009CN101560193A Alpha-polyhalide acetyl piperazinyl oxazolidone compound and antibacterium application thereof
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 210